Literature DB >> 19735902

Establishing "best practices" for opioid rotation: conclusions of an expert panel.

Perry G Fine1, Russell K Portenoy.   

Abstract

Opioid rotation is a strategy applied during opioid therapy for pain that refers to a switch from one opioid to another in an effort to improve clinical outcomes (benefits or harms). It begins with the selection of a new drug at a starting dose that minimizes potential risks while ideally maintaining analgesic efficacy. The selection of a starting dose must be informed by an estimate of the relative potency between the existing opioid and the new one. Clinically relevant estimates of relative analgesic potency have been codified in the "equianalgesic dose table," which has been used with little modification for more than 40 years. New information about relative potency and the growing implementation of long-term opioid therapy for chronic pain provided a strong rationale for the convening of an expert panel to discuss the scientific foundation to opioid rotation and the elements that now should inform a clinical guideline for this practice. The panel affirmed both the value and the limitations of the current equianalgesic dose table and proposed a guideline intended to promote safety during opioid rotation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19735902      PMCID: PMC4065110          DOI: 10.1016/j.jpainsymman.2009.06.002

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  10 in total

Review 1.  Equianalgesic dose ratios for opioids. a critical review and proposals for long-term dosing.

Authors:  J Pereira; P Lawlor; A Vigano; M Dorgan; E Bruera
Journal:  J Pain Symptom Manage       Date:  2001-08       Impact factor: 3.612

2.  Methadone for pain: No. 75.

Authors:  G Gazelle; P G Fine
Journal:  J Palliat Med       Date:  2004-04       Impact factor: 2.947

3.  Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study.

Authors:  P G Lawlor; K S Turner; J Hanson; E D Bruera
Journal:  Cancer       Date:  1998-03-15       Impact factor: 6.860

4.  A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer.

Authors:  Russell K Portenoy; Donald Taylor; John Messina; Lothar Tremmel
Journal:  Clin J Pain       Date:  2006 Nov-Dec       Impact factor: 3.442

5.  Impact of ethnic origin and quinidine coadministration on codeine's disposition and pharmacodynamic effects.

Authors:  Y Caraco; J Sheller; A J Wood
Journal:  J Pharmacol Exp Ther       Date:  1999-07       Impact factor: 4.030

6.  Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Authors:  Roger Chou; Gilbert J Fanciullo; Perry G Fine; Jeremy A Adler; Jane C Ballantyne; Pamela Davies; Marilee I Donovan; David A Fishbain; Kathy M Foley; Jeffrey Fudin; Aaron M Gilson; Alexander Kelter; Alexander Mauskop; Patrick G O'Connor; Steven D Passik; Gavril W Pasternak; Russell K Portenoy; Ben A Rich; Richard G Roberts; Knox H Todd; Christine Miaskowski
Journal:  J Pain       Date:  2009-02       Impact factor: 5.820

Review 7.  Opioid switching to improve pain relief and drug tolerability.

Authors:  C Quigley
Journal:  Cochrane Database Syst Rev       Date:  2004

Review 8.  Opioid rotation: the science and the limitations of the equianalgesic dose table.

Authors:  Helena Knotkova; Perry G Fine; Russell K Portenoy
Journal:  J Pain Symptom Manage       Date:  2009-09       Impact factor: 3.612

9.  Long-term methadone maintenance reduces protracted symptoms of heroin abstinence and cue-induced craving in Chinese heroin abusers.

Authors:  Jie Shi; Li-Yan Zhao; David H Epstein; Xiao-Li Zhang; Lin Lu
Journal:  Pharmacol Biochem Behav       Date:  2007-04-21       Impact factor: 3.533

10.  Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?

Authors:  C Ripamonti; L Groff; C Brunelli; D Polastri; A Stavrakis; F De Conno
Journal:  J Clin Oncol       Date:  1998-10       Impact factor: 44.544

  10 in total
  53 in total

Review 1.  Pragmatic Opioid Use in Painful Diabetic Neuropathy.

Authors:  Yatan Pal Singh Balhara; Shalini Singh; Sanjay Kalra
Journal:  Eur Endocrinol       Date:  2020-02-04

2.  [Cancer pain in palliative medicine].

Authors:  R Laufenberg-Feldmann; R Schwab; R Rolke; M Weber
Journal:  Internist (Berl)       Date:  2012-02       Impact factor: 0.743

Review 3.  [Cancer pain in palliative medicine].

Authors:  R Laufenberg-Feldmann; R Schwab; R Rolke; M Weber
Journal:  Anaesthesist       Date:  2012-05       Impact factor: 1.041

Review 4.  [Update palliative pain therapy].

Authors:  R Rolke; S Rolke; S Hiddemann; M Mücke; H Cuhls; L Radbruch; F Elsner; V Peuckmann-Post
Journal:  Internist (Berl)       Date:  2016-10       Impact factor: 0.743

5.  A prospective, open-label, multicenter study of the clinical efficacy of extended-release hydromorphone in treating cancer pain inadequately controlled by other analgesics.

Authors:  Hye-Suk Han; Ki Hyeong Lee; Kyung Hee Lee; Jeong Seon Ryu; Young Chul Kim; Seung Woo Park; Ho-Suk Oh; Kyung Tae Park; Jung Hye Kwon; Pyung Bok Lee; Won Sik Lee; Yang Soo Kim; Joong Bae Ahn; Seong Woo Jeon; Sung Yong Lee; Young Mi Seol; Jung Hun Kang; Young Jin Yuh; So Yeon Oh; Suk Ran Kim; Jin Seok Ahn
Journal:  Support Care Cancer       Date:  2013-11-08       Impact factor: 3.603

6.  Racial differences in primary care opioid risk reduction strategies.

Authors:  William C Becker; Joanna L Starrels; Moonseong Heo; Xuan Li; Mark G Weiner; Barbara J Turner
Journal:  Ann Fam Med       Date:  2011 May-Jun       Impact factor: 5.166

7.  Effects of opioid rotation in chronic pain patients: ORTIBARN study.

Authors:  Antonio Gatti; Carlo Reale; Marta Luzi; Alessandra Canneti; Rocco Domenico Mediati; Renato Vellucci; Massimo Mammucari; Alessandro Fabrizio Sabato
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

8.  A Practical Approach to Acute Postoperative Pain Management in Chronic Pain Patients.

Authors:  Edwin N Aroke; Susan P McMullan; Katie O Woodfin; Ryan Richey; Jordan Doss; Bryan A Wilbanks
Journal:  J Perianesth Nurs       Date:  2020-07-11       Impact factor: 1.084

Review 9.  Opioid-induced bowel dysfunction: epidemiology, pathophysiology, diagnosis, and initial therapeutic approach.

Authors:  Spencer Dorn; Anthony Lembo; Filippo Cremonini
Journal:  Am J Gastroenterol Suppl       Date:  2014-09-10

10.  Opioid switching and variability in response in pain cancer patients.

Authors:  O Corli; A Roberto; N Corsi; F Galli; M Pizzuto
Journal:  Support Care Cancer       Date:  2018-10-24       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.